• GUERBET : Financial agenda for 2025

    Source: Nasdaq GlobeNewswire / 31 Oct 2024 12:00:00   America/Chicago

    Financial agenda for 2025

    Villepinte, 31 October 2024: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is announcing its financial agenda for 2025.

    Publications calendar
    • 2024 ANNUAL REVENUE
    February 06, 2025, after trading
    • 2024 ANNUAL RESULTS
    March 27, 2025, after trading
    • 2025 1st QUARTER REVENUE
    April 24, 2025, after trading
    • ANNUAL SHAREHOLDERS’ MEETING
    May 23, 2025
    • 2025 2nd QUARTER REVENUE
    July 24, 2025, after trading
    • 2025 FIRST HALF RESULTS
    September 25, 2025, after trading
    • 2025 3rd QUARTER REVENUE
    October 23, 2025, after trading

    About Guerbet

    At Guerbet, we build lasting relationships so that we enable people to live better. That is our purpose. We are a leader in medical imaging worldwide, offering a comprehensive range of pharmaceutical products, medical devices, and digital and AI solutions for diagnostic and interventional imaging. A pioneer in contrast media for 95 years, with more than 2,600 employees worldwide, we continuously innovate and devote 10% of our sales to research and development in four centres in France, in United States and Israël. Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €786 million in revenue in 2023.



    Contacts:

    Guerbet     
    Jérôme Estampes, Chief Financial Officer + 33 1 45 91 50 00 / jerome.estampes@guerbet.com 
    Christine Allard, Head of Public Affairs and Communications: +33 6 30 11 57 82 / christine.allard@guerbet.com

    Seitosei.Actifin                                                                                       
    Marianne Py, Financial Communication + 33 1 80 48 25 31 / marianne.py@seitosei-actifin.com
    Jennifer Jullia, Press +33 1 56 88 11 19 / jennifer.jullia@seitosei-actifin.com

    Attachment


Share on,